Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin.
暂无分享,去创建一个
[1] C. Bogdan,et al. Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[2] R. Gläser. Research in practice: Antimicrobial peptides of the skin , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[3] J. Brasch. Pathogenesis of tinea , 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[4] J. Brasch. Current knowledge of host response in human tinea , 2009, Mycoses.
[5] R. Nagaraj,et al. Antifungal Activities of Human Beta-Defensins HBD-1 to HBD-3 and Their C-Terminal Analogs Phd1 to Phd3 , 2008, Antimicrobial Agents and Chemotherapy.
[6] Guoxing Wang,et al. Antimicrobial host defense in the upper gastrointestinal tract , 2008, European journal of gastroenterology & hepatology.
[7] M. Kleine,et al. Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis. , 2007, The Journal of investigative dermatology.
[8] S. Vylkova,et al. Human β-Defensins Kill Candida albicans in an Energy-Dependent and Salt-Sensitive Manner without Causing Membrane Disruption , 2006, Antimicrobial Agents and Chemotherapy.
[9] J. Schröder,et al. Antimicrobial skin peptides and proteins , 2006, Cellular and Molecular Life Sciences CMLS.
[10] M. Ghannoum,et al. Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans , 2005, Journal of dental research.
[11] J. Schröder,et al. Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins , 2005, Journal of leukocyte biology.
[12] Maria José Figueras,et al. Atlas of clinical fungi. , 2005 .
[13] J. Schröder,et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.
[14] P. Lachmann,et al. The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins , 2004, Immunology.
[15] J. Schröder,et al. RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin* , 2002, The Journal of Biological Chemistry.
[16] C. Brissette,et al. Treponema denticola Is Resistant to Human β-Defensins , 2002, Infection and Immunity.
[17] Christina H. Park,et al. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. , 2002, The Journal of investigative dermatology.
[18] C. Brissette,et al. Treponema denticola is resistant to human beta-defensins. , 2002, Infection and immunity.
[19] J. Schröder,et al. Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.
[20] M. Watson,et al. Burkholderia cepacia is resistant to the antimicrobial activity of airway epithelial cells. , 1999, Immunopharmacology.
[21] J. Nyborg,et al. Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. , 1999, Biochemistry.
[22] J. Schröder,et al. A peptide antibiotic from human skin , 1997, Nature.
[23] A. Padhye,et al. Dermatophytes: gross and microscopic. , 1996, Dermatologic clinics.
[24] R. Summerbell,et al. The dermatophytes , 1995, Clinical microbiology reviews.